Day 1 - 22 April 2013

8:00-9:15	Registration
9:15-9:30	Opening Avi Treves Sheba Cancer Research Center, Chairman, Israstem 2013, Israel
09:30 - 10:10 Plenary Session: Chair: Avi Treves	Repurposing Cord Blood for Transplantation and Regenerative Medicine Joanne Kurtzberg Duke University Medical Center NC, USA
10:10 - 10:40	Coffee break
	Hall A - Rayman Central	Hall B - Rayman West
10:40-12:40	Session A: Clinical Studies in Progress Chair: Joseph Itskovitz-Eldor Technion - Israel Institute of Technology, Rambam Health Care Campus, Accellta Ltd., Haifa, Israel	Session B: Tools for Research and Development Chair: Eytan Abraham Product Innovation Research Manager Pluristem, Israel
10:40 - 11:00 Keynote Lecture:	Transplantation of Mesenchymal Stromal Cells Secreting Neurotrophic Factors Shows Safety and Initial Indications of Clinical Benefit in ALS Patients in a Phase I/II Clinical Trial Daniel Offen BrainStorm Cell Therapeutics Ltd., Petach-Tikva, Israel	Development of a Scale Up Process for Undifferentiated Human Pluripotent Stem Cells in an Industrial Bioreactor Michal Amit Stem Cells Center, Technion Faculty of Medicine, Haifa, Israel
11:00 - 11:20	Bringing Your Stem Cell Product to Market Faster D. A. Prasanna GM Ecron Acunova CRO, Bangalore, India	Cytokines and Growth Factors Used as Raw Materials for Cell and Tissue Based Products Bernd Leistler Development & Production, CellGenix GmbH, Freiburg, Germany
11:20 - 11:40	Intramyocardial Delivered Mesenchymal Stromal Cells Therapy in Patients with Chronic Refractory Angina – 3 Years Follow-up Jens Kastrup Cardiology Stem Cell Center, Department of Cardiology, Rigshospitalet Copenhagen University Hospital, Copenhagen, Denmark	Toward a Serum-Free, Xeno-Free Culture System for Optimal Growth and Expansion of hMSC Suited to Therapeutic Applications Mira Genser-Nir Biological Industries, Kibbutz Beit Haemek, Israel
11:40 - 12:00	A Prospective Multi-Center 24 Week Observational Study Evaluating Wound Healing Outcomes in 131 Patients Treated with Human Activated Leukocytes Suspension, an Advanced Cell Therapy Adi Zuloff-Shani Macrocure, Ramat-Gan, Israel	A Novel Method for Subretinal Transplantation of Human Adult Bone Marrow Mesenchymal Stem Cells Ameliorates the Deterioration of Retinal Structure and Function in a Rat Model of Retinal Dystrophies Ygal Rotenstreich Goldschleger Eye Research Institute, Tel Aviv University, Sheba Medical Center, Tel Hashomer, Israel
12:00 - 12:20	Adoptive Transfer of Tumor Infiltrating Lymphocytes in Metastatic Melanoma Patients: Intent-to-Treat Analysis and Efficacy after Failure to Prior Immunotherapies Michal J Besser Ella Institute for Melanoma, Sheba Medical Center, Ramat Gan, Israel	Cell Therapy Compliant Culture Systems for Stem Cells Mohan Vemuri R&D, Primary & Stem Cell Division, Life Technologies, Frederick, MD, USA
12:20-12:40	Single-Infusion of Donor Early Apoptotic Cells (Apocell) as Prophylaxis for Graft-Versus-Host Disease in Myeloablative HLA-Matched Allogeneic Bone Marrow Transplantation. A Phase I-IIa Clinical Trial Dror Mevorach Enlivex, Jerusalem, Israel	An Innovative Manufacturing Strategy to Expand MSCs Using a Closed and Automated Device – A Case Study Stefano Baila Terumo BCT, Zaventem, Belgium
12:30 - 14:00	Lunch break
14:00 - 14:40 Plenary Session: Chair: Shosh Merchav	Cell Therapy: The First Step into the Emerging New Age of Regenerative Medicine Christopher Calhoun Cytori Therapeutics, San Diego, USA
14:40 - 15:10	Coffee break
	Hall A - Rayman Central	Hall B - Rayman West
15:10-16:50	Session C: New Technologies in Translation Chair: Benjamin Dekel Pediatric Stem Cell Research Institute, Sheba Medical Center & KidneyCure, Israel	Session D: Israel – Start Up Nation Chair: Shosh Merchav CEO, Multifacet Biosolutions Ltd., Israel
15:10 - 15:30 Keynote Lecture:	Human Pluripotent Stem Cells: Implications for Basic and Translational Cardiac Research Lior Gepstein Medicine, Technion, Haifa, Israel	The Gamida Cell Chronicles: Diary of a Clinical Adventure Einat Galamidi Cohen Gamida Cell, Jerusalem, Israel
15:30 - 15:50	Biomaterials for Translational Regenerative Medicine Smadar Cohen Biotechnology Engineering, Ben-Gurion University, Beer Sheva, Israel	A Novel Technology for Replenishment of Articular Lesions Gila Maor Anatomy and Сell Biology, Technion / Carticure Ltd., Haifa, Israel
15:50 - 16:10	Engineering Stem Cell Microenvironments for Controlled Induction of Differentiation Shulamit Levenberg Biomedical Engineering, Technion, Haifa, Israel	Cellection of Stem Cells - Moving from Membrane to Function Shai Yarkoni Cellect Biotechnology Ltd., Kfar-Saba, Israel
16:10 - 16:30	Committed Embryonic Tissue as a Novel Source for Tissue Regeneration Yair Reisner Immunology, Weizmann Institute of Science, Rehovot, Israel	Kadimastem: Stem Cells to Cure Diseases Arik Hasson Research & Development, Kadimastem Ltd, Ness Ziona, Israel
16:30 – 16:50	Implementation of Advanced Autologous Cell-Based Therapy for Diabetic Patients Sarah Ferber Orgenesis, Haifa, Israel	Human Embryonic Stem Cells in The Fight to Save Sight Charles Irving Cell Cure Neurosciences Ltd., Jerusalem, Israel